Drug Side Effects
Search
PLEUROPARENCHYMAL FIBROELASTOSIS
PLEUROPARENCHYMAL FIBROELASTOSIS
was reported 104 times
These drug classes are most commonly taken by patients reporting PLEUROPARENCHYMAL FIBROELASTOSIS:
#
Drug
Count
0
Alkylating Drug [EPC]
52
1
Corticosteroid [EPC]
46
2
Topoisomerase Inhibitor [EPC]
28
3
Nucleoside Metabolic Inhibitor [EPC]
23
4
Folate Analog Metabolic Inhibitor [EPC]
17
5
Purine Antimetabolite [EPC]
11
6
Kinase Inhibitor [EPC]
8
7
Retinoid [EPC]
8
8
Janus Kinase Inhibitor [EPC]
7
9
Platinum-based Drug [EPC]
7
10
Actinomycin [EPC]
6
11
Antimetabolite [EPC]
6
12
CD20-directed Cytolytic Antibody [EPC]
6
13
Glycolipid Disialoganglioside-directed Antibody [EPC]
3
14
Lymphocyte Growth Factor [EPC]
3
15
Aminosalicylate [EPC]
2
16
Anti-IgE [EPC]
2
17
Programmed Death Receptor-1 Blocking Antibody [EPC]
2
18
Proton Pump Inhibitor [EPC]
2
19
Pyridone [EPC]
2
20
Tumor Necrosis Factor Blocker [EPC]
2
21
Alkaloid [EPC]
1
22
Aminoglycoside Antibacterial [EPC]
1
23
Antimetabolite Immunosuppressant [EPC]
1
24
Aromatase Inhibitor [EPC]
1
25
Benzodiazepine [EPC]
1
26
Estrogen Receptor Antagonist [EPC]
1
27
Factor Xa Inhibitor [EPC]
1
28
Interleukin-4 Receptor alpha Antagonist [EPC]
1
29
Lipopeptide Antibacterial [EPC]
1
30
Macrolide Antimicrobial [EPC]
1
31
Macrolide [EPC]
1
32
Microtubule Inhibitor [EPC]
1
33
Selective T Cell Costimulation Modulator [EPC]
1
34
Tetracycline-class Drug [EPC]
1